Replies to post #395327 on Zeev's Turnips Patch-No Politics (ZEEV)

[marginnayan]

EYET - From SI - by MD

It's too bad wall street does not understand the pathophysiology of wet AMD. No drug can reverse the retinal damage of AMD. VEGF inhibitors may slow down or at best stop further damage. Vision improvement suggested in the Genentech trial is probably due to reduction in macular edema and should therefore be limited. Once the edema is reduced then no further improvement should be expected. Critical review of Genentech data and study design is needed.

----

Here goes DNA's drug claim for vision improvement

[marginnayan]

EYET conf call starts in 1 hour

http://www.eyetech.com/investors/Press_Releases.asp